BioAffinity Technologies, Inc. (NASDAQ:BIAF) shares are moving higher on Tuesday after the company reported 2024 fiscal-year earnings, showing multiple year-over-year increases. What To Know: The ...

BioAffinity Technologies, Inc. (NASDAQ:BIAF) shares are trading lower by 50.7% to $1.48 during Wednesday’s session after the company announced a securities purchase agreement with institutional ...

Zacks Investment Research has recently initiated coverage of bioAffinity Technologies, Inc. BIAF, assigning a "Neutral" recommendation to the company's shares. This assessment comes amid a mixed ...

SAN ANTONIO - bioAffinity Technologies, Inc. (NASDAQ:BIAF; BIAFW), a company specializing in noninvasive early-stage lung cancer diagnostics, announced today the acceptance of its patent application ...

SAN ANTONIO, March 06, 2025--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage ...

bioAffinity Technologies also announced that Gary Rubin stepped down from the Board of Directors for personal reasons and not due to any disagreement with the Company or its operations, policies or ...

Affinity Technologies, Inc. ( ($BIAF) ) just unveiled an update. On December 19, 2025, bioAffinity Technologies, Inc. convened but immediately ...

SAN ANTONIO--(BUSINESS WIRE)--Here is a summary of the latest news about bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the ...

SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies’ (Nasdaq: BIAF; BIAFW) Vice President of Diagnostics, Jennifer Rebeles, Ph.D., was part of a panel of worldwide experts that published the ...

San Antonio-based biotech company bioAffinity raised over $4 million as it plans to bring its new lung cancer test to market next year, according to securities filings. The funding round, which closed ...